138 related articles for article (PubMed ID: 16368743)
21. Phospholipid transfer protein is regulated by liver X receptors in vivo.
Cao G; Beyer TP; Yang XP; Schmidt RJ; Zhang Y; Bensch WR; Kauffman RF; Gao H; Ryan TP; Liang Y; Eacho PI; Jiang XC
J Biol Chem; 2002 Oct; 277(42):39561-5. PubMed ID: 12177004
[TBL] [Abstract][Full Text] [Related]
22. Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.
Qin Y; Dalen KT; Gustafsson JA; Nebb HI
Biochim Biophys Acta; 2009 Feb; 1791(2):140-7. PubMed ID: 19136075
[TBL] [Abstract][Full Text] [Related]
23. Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels.
Zitzer H; Wente W; Brenner MB; Sewing S; Buschard K; Gromada J; Efanov AM
Endocrinology; 2006 Aug; 147(8):3898-905. PubMed ID: 16644917
[TBL] [Abstract][Full Text] [Related]
24. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
Chonlaket P; Wongwan T; Soodvilai S
Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
[TBL] [Abstract][Full Text] [Related]
25. The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression.
Pawar A; Botolin D; Mangelsdorf DJ; Jump DB
J Biol Chem; 2003 Oct; 278(42):40736-43. PubMed ID: 12917410
[TBL] [Abstract][Full Text] [Related]
26. Induction of stearoyl-CoA desaturase protects human arterial endothelial cells against lipotoxicity.
Peter A; Weigert C; Staiger H; Rittig K; Cegan A; Lutz P; Machicao F; Häring HU; Schleicher E
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E339-49. PubMed ID: 18523127
[TBL] [Abstract][Full Text] [Related]
27. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
[TBL] [Abstract][Full Text] [Related]
28. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
[TBL] [Abstract][Full Text] [Related]
29. Dietary cholesterol opposes PUFA-mediated repression of the stearoyl-CoA desaturase-1 gene by SREBP-1 independent mechanism.
Kim HJ; Miyazaki M; Ntambi JM
J Lipid Res; 2002 Oct; 43(10):1750-7. PubMed ID: 12364560
[TBL] [Abstract][Full Text] [Related]
30. [Activation of liver X receptor regulates fatty acid synthase expression in diabetic liver].
Wang B; Cheng LJ; Gao ZN; Zhang XY; Huo M; Zhang DJ; Wu J; Wei MF
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):848-52. PubMed ID: 18756992
[TBL] [Abstract][Full Text] [Related]
31. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.
Repa JJ; Liang G; Ou J; Bashmakov Y; Lobaccaro JM; Shimomura I; Shan B; Brown MS; Goldstein JL; Mangelsdorf DJ
Genes Dev; 2000 Nov; 14(22):2819-30. PubMed ID: 11090130
[TBL] [Abstract][Full Text] [Related]
32. Activation of liver X receptor inhibits OCT2-mediated organic cation transport in renal proximal tubular cells.
Wongwan T; Kittayaruksakul S; Asavapanumas N; Chatsudthipong V; Soodvilai S
Pflugers Arch; 2017 Nov; 469(11):1471-1481. PubMed ID: 28741179
[TBL] [Abstract][Full Text] [Related]
33. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.
Repa JJ; Berge KE; Pomajzl C; Richardson JA; Hobbs H; Mangelsdorf DJ
J Biol Chem; 2002 May; 277(21):18793-800. PubMed ID: 11901146
[TBL] [Abstract][Full Text] [Related]
34. [Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells].
Yu B; Wu J; Zhang XY; Chen LH; Yang GR; Wei MF; Xing CY; Guan YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):244-8. PubMed ID: 16778964
[TBL] [Abstract][Full Text] [Related]
35. Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists.
Liang Y; Jiang XC; Liu R; Liang G; Beyer TP; Gao H; Ryan TP; Dan Li S; Eacho PI; Cao G
Mol Endocrinol; 2004 Aug; 18(8):2000-10. PubMed ID: 15131258
[TBL] [Abstract][Full Text] [Related]
36. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
[TBL] [Abstract][Full Text] [Related]
37. Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells.
Wu J; Zhang Y; Wang N; Davis L; Yang G; Wang X; Zhu Y; Breyer MD; Guan Y
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F886-95. PubMed ID: 15280160
[TBL] [Abstract][Full Text] [Related]
38. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.
Liang G; Yang J; Horton JD; Hammer RE; Goldstein JL; Brown MS
J Biol Chem; 2002 Mar; 277(11):9520-8. PubMed ID: 11782483
[TBL] [Abstract][Full Text] [Related]
39. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
Bełtowski J
Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
[TBL] [Abstract][Full Text] [Related]
40. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
